These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24637888)

  • 1. Oligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development.
    Barresi S; Tomaselli S; Athanasiadis A; Galeano F; Locatelli F; Bertini E; Zanni G; Gallo A
    PLoS One; 2014; 9(3):e91351. PubMed ID: 24637888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the phenotypic spectrum associated with OPHN1 mutations: Report of 17 individuals with intellectual disability but no cerebellar hypoplasia.
    Moortgat S; Lederer D; Deprez M; Buzatu M; Clapuyt P; Boulanger S; Benoit V; Mary S; Guichet A; Ziegler A; Colin E; Bonneau D; Maystadt I
    Eur J Med Genet; 2018 Aug; 61(8):442-450. PubMed ID: 29510240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel in-frame deletion affecting the BAR domain of OPHN1 in a family with intellectual disability and hippocampal alterations.
    Santos-Rebouças CB; Belet S; Guedes de Almeida L; Ribeiro MG; Medina-Acosta E; Bahia PR; Alves da Silva AF; Lima dos Santos F; Borges de Lacerda GC; Pimentel MM; Froyen G
    Eur J Hum Genet; 2014 May; 22(5):644-51. PubMed ID: 24105372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exon 21 deletion in the OPHN1 gene in a family with syndromic X-linked intellectual disability: Case report.
    Bogliş A; Cosma AS; Tripon F; Bãnescu C
    Medicine (Baltimore); 2020 Aug; 99(33):e21632. PubMed ID: 32872024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia.
    Bergmann C; Zerres K; Senderek J; Rudnik-Schoneborn S; Eggermann T; Häusler M; Mull M; Ramaekers VT
    Brain; 2003 Jul; 126(Pt 7):1537-44. PubMed ID: 12805098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological features in a female fetus with OPHN1 deletion and cerebellar hypoplasia.
    Rocas D; Alix E; Michel J; Cordier MP; Labalme A; Guilbert H; Till M; Schluth-Bolard C; de Haas P; Massardier J; Portes Vd; Edery P; Touraine R; Guibaud L; Vasiljevic A; Sanlaville D
    Eur J Med Genet; 2013 May; 56(5):270-3. PubMed ID: 23416624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the OPHN1 gene detected by aCGH.
    Madrigal I; Rodríguez-Revenga L; Badenas C; Sánchez A; Milà M
    J Intellect Disabil Res; 2008 Mar; 52(Pt 3):190-4. PubMed ID: 18261018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1.
    Nakano-Kobayashi A; Kasri NN; Newey SE; Van Aelst L
    Curr Biol; 2009 Jul; 19(13):1133-9. PubMed ID: 19481455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability.
    Busti I; Allegra M; Spalletti C; Panzi C; Restani L; Billuart P; Caleo M
    J Neurosci; 2020 Mar; 40(13):2776-2788. PubMed ID: 32098904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance.
    Al-Owain M; Kaya N; Al-Zaidan H; Al-Hashmi N; Al-Bakheet A; Al-Muhaizea M; Chedrawi A; Basran RK; Milunsky A
    Clin Genet; 2011 Apr; 79(4):363-70. PubMed ID: 20528889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the study of OPHN1 gene].
    Zhang LJ; Zhang FC; Gao XC
    Sheng Li Ke Xue Jin Zhan; 2006 Jan; 37(1):69-71. PubMed ID: 16683552
    [No Abstract]   [Full Text] [Related]  

  • 12. Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function.
    Compagnucci C; Barresi S; Petrini S; Billuart P; Piccini G; Chiurazzi P; Alfieri P; Bertini E; Zanni G
    Stem Cells Transl Med; 2016 Jul; 5(7):860-9. PubMed ID: 27160703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of a female patient with mental retardation and tall stature due to a chromosomal rearrangement disrupting the OPHN1 gene on Xq12.
    Menten B; Buysse K; Vermeulen S; Meersschaut V; Vandesompele J; Ng BL; Carter NP; Mortier GR; Speleman F
    Eur J Med Genet; 2007; 50(6):446-54. PubMed ID: 17845870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel unconventional variants expand the allelic spectrum of OPHN1 gene.
    Nuovo S; Brankovic V; Caputi C; Casella A; Nigro V; Leuzzi V; Valente EM
    Am J Med Genet A; 2021 May; 185(5):1575-1581. PubMed ID: 33638601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligophrenin-1 regulates number, morphology and synaptic properties of adult-born inhibitory interneurons in the olfactory bulb.
    Redolfi N; Galla L; Maset A; Murru L; Savoia E; Zamparo I; Gritti A; Billuart P; Passafaro M; Lodovichi C
    Hum Mol Genet; 2016 Dec; 25(23):5198-5211. PubMed ID: 27742778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of 16 amino acids in the BAR domain of the oligophrenin 1 protein causes mental retardation and cerebellar hypoplasia in an Italian family.
    Pirozzi F; Di Raimo FR; Zanni G; Bertini E; Billuart P; Tartaglione T; Tabolacci E; Brancaccio A; Neri G; Chiurazzi P
    Hum Mutat; 2011 Nov; 32(11):E2294-307. PubMed ID: 21796728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    Dawson TR; Sansam CL; Emeson RB
    J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia.
    Zanni G; Saillour Y; Nagara M; Billuart P; Castelnau L; Moraine C; Faivre L; Bertini E; Durr A; Guichet A; Rodriguez D; des Portes V; Beldjord C; Chelly J
    Neurology; 2005 Nov; 65(9):1364-9. PubMed ID: 16221952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis.
    Govek EE; Newey SE; Akerman CJ; Cross JR; Van der Veken L; Van Aelst L
    Nat Neurosci; 2004 Apr; 7(4):364-72. PubMed ID: 15034583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil treatment in adult reverses behavioural changes and brain ventricular enlargement in Oligophrenin-1 mouse model of intellectual disability.
    Meziane H; Khelfaoui M; Morello N; Hiba B; Calcagno E; Reibel-Foisset S; Selloum M; Chelly J; Humeau Y; Riet F; Zanni G; Herault Y; Bienvenu T; Giustetto M; Billuart P
    Hum Mol Genet; 2016 Jun; 25(11):2314-2323. PubMed ID: 27146843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.